Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls

Clinical Infectious Diseases

Volumn 60, Issue 7, 2015, Pages 1111-1119

  Cohen, Sophie ^a   Ter Stege, Jacqueline A ^a   Geurtsen, Gert J ^a   Scherpbier, Henriette J ^a   Kuijpers, Taco W ^a   Reiss, Peter ^a,b,c   Schmand, Ben ^a   Pajkrt, Dasja ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b STICHTING HIV MONITORING   (Netherlands)

^c Center for Infection and Immunity Amsterdam   (Netherlands)

Author keywords

children; cognitive performance; HIV; SES

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ADOLESCENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOMEGALOVIRUS ENCEPHALITIS; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ENCEPHALITIS; ETHNICITY; EXECUTIVE FUNCTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING SPEED; INTELLIGENCE QUOTIENT; LEARNING; MALE; MEMORY; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PERINATAL INFECTION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SOCIAL STATUS; VISUOMOTOR COORDINATION; CASE CONTROL STUDY; CHILD; CHILD DEVELOPMENT; COGNITION DISORDERS; COMPLICATION; PATHOLOGY; PHYSIOLOGY;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE;

EID: 84926679680     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu1144     Document Type: Article

References (48)

1. Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, Seage GR. Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS 2009; 23:1893-901.
2. Puthanakit T, Ananworanich J, Vonthanak S, et al. Cognitive function and neurodevelopmental outcomes in HIV-infected children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J 2013; 32:501-8.
3. Boyede GO, Lesi FE, Ezeaka VC, Umeh CS. Impact of sociodemographic factors on cognitive function in school-Aged HIV-infected Nigerian children. HIV AIDS 2013; 5:145-52.
4. Ruel TD, Boivin MJ, Boal HE, et al. Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. Clin Infect Dis 2012; 54:1001-9.
5. Puthanakit T, Aurpibul L, Louthrenoo O, et al. Poor cognitive functioning of school-Aged children in Thailand with perinatally acquired HIV infection taking antiretroviral therapy. AIDS Patient Care STDS 2010; 24:141-6.
6. Smith R, Malee K, Leighty R, et al. Effects of perinatal HIV infection and associated risk factors on cognitive development among young children. Pediatrics 2006; 117:851-62.
7. Shanbhag MC, Rutstein RM, Zaoutis T, Zhao H, Chao D, Radcliffe J. Neurocognitive functioning in pediatric human immunodeficiency virus infection. Arch Pediatr 2012; 159:651-6.
8. Nozyce ML, Lee SS, Wiznia A, et al. A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics 2006; 117:763-70.
9. Brackis-Cott E, Kang E, Dolezal C, Abrams EJ, Mellins CA. The impact of perinatal HIV infection on older school-Aged children's and adolescents' receptive language and word recognition skills. AIDS Patient Care STDS 2009; 23:415-21.
10. Rice ML, Buchanan AL, Siberry GK, et al. Language impairment in children perinatally infected with HIV compared to children who were HIV-exposed and uninfected. J Dev Behav Pediatr 2012; 33:112-23.
11. Blanchette N, Lou Smith M, King S, Fernandes-Penney A, Read S. Developmental neuropsychology cognitive development in school-Age children with vertically transmitted HIV infection. Dev Neuropsychol 2002; 21:223-41.
12. Smith R, Chernoff M, Williams PL, et al. Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J 2012; 31:592-8.
13. Martin SC, Wolters PL, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L. Cognitive functioning in school-Aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART). Dev Neuropsychol 2006; 30:633-57.
14. Nachman S, Chernoff M, Williams P, Hodge J, Heston J, Gadow KD. Human immunodeficiency virus disease severity, psychiatric symptoms, and functional outcomes in perinatally infected youth. Arch Pediatr Adolesc Med 2012; 166:528-35.
15. Lindsey JC, Malee KM, Brouwers P, Hughes MD. Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy. Pediatrics 2007; 119:681-93.
16. Raskino C, Pearson DA, Baker CJ, et al. Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team. Pediatrics 1999; 3:104-32.
17. Laughton B, Cornell M, Boivin M, Rie A. Neurodevelopment in perinatally HIV-infected children: a concern for adolescence. J Int AIDS Soc 2013; 16:18603.
18. Koekkoek S, Eggermont L, De Sonneville L, et al. Effects of highly active antiretroviral therapy (HAART) on psychomotor performance in children with HIV disease. J Neurol 2006; 253:1615-24.
19. Giraudon I, Forde J, Maguire H, Arnold J, Permalloo N. Antenatal screening and prevalence of infection: surveillance in London, 2000-2007. Eurosurveill 2007; 14:1-5.
20. Cohen S, Smit C, van Rossum AMC, et al. Long-Term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996-2012. AIDS 2013; 27:2567-75.
21. Christensen DL, Schieve LA, Devine O, Drews-Botsch C. Socioeconomic status, child enrichment factors, and cognitive performance among preschool-Age children: results from the follow-up of growth and development experiences study. Res Dev Disabil 2014; 35:1789-801.
22. Bradley R, Corwyn R. Socioeconomic status and child development. Ann Rev Psych 2002; 53:371-99.
23. Pearlstein SL, Mellins CA, Dolezal C, et al. Youth in transition: life skills among perinatally HIV-infected and HIV-exposed adolescents. J Pediatr Psychol 2013; 39:294-305.
24. Kandawasvika GQ, Kuona P, Chandiwana P, et al. The burden and predictors of cognitive impairment among 6-To 8-year-old children infected and uninfected with HIV from Harare, Zimbabwe: a cross-sectional study. Child Neuropsychol 2015; 21:106-20.
25. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-Associated neurocognitive disorders. Neurology 2007; 69: 1789-99.
26. Gisslen M, Price RW, Nilsson S. The definition of HIV-Associated neurocognitive disorders: are we overestimating the real prevalence?. BMC Infect Dis 2011; 11:356.
27. Schouten J, Geurtsen GJ, Wit FWNM, et al. Novel method for more reliably estimating the burden of cognitive impairment in HIV. In: Conference on Retroviruses and Opportunistic Infections, Boston, MA 3-6 March 2014. Abstract 481.
28. Huizenga HM, Smeding H, Grasman RPPP, Schmand B. Multivariate normative comparisons. Neuropsychologia 2007; 45:2534-42.
29. Bicknese L, Slot J. Staat van de aandachtswijken. Gemeente Amsterdam Dienst Onderzoek en Statistiek; 2009; Project 9107.
30. Dutch HIV Monitoring Foundation. Available at: http://www.hivmonitoring. nl/english/medical-professionals/patient-data-collection/. Accessed 11 August 2014.
31. Comans-Bitter WM, de Groot R, van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997; 130:388-93.
32. Wechsler D. Wechsler Intelligence Scale manual. 3rd ed. Amsterdam: Pearson Assessment, 2002.
33. Wechsler D. Wechsler Adult Intelligence Scale manual. 3rd ed Amsterdam: Pearson Assessment, 2000.
34. Mortensen EL, Andresen J, Kruuse E, Sanders SA, Reinisch JM. IQ stability: the relation between child and young adult intelligence test scores in low-birthweight samples. Scand J Psychol 2003; 44:395-8.
35. Sirois PA, Posner M, Stehbens JA, et al. Quantifying practice effects in longitudinal research with the WISC-R andWAIS-R: a study of children and adolescents with hemophilia and male siblings without hemophilia. J Pediatr Psychol 2002; 27:121-31.
36. Hijmans CT, Grootenhuis MA, Oosterlaan J, Heijboer H, Peters M, Fijnvandraat K. Neurocognitive deficits in children with sickle cell disease are associated with the severity of anemia. Pediatr Blood Cancer 2011; 57:297-302.
37. Baron IS. Neuropsychological evaluation of the child. Oxford: Oxford University Press, 2004.
38. Rey A. L'examen clinique en psychologie. Paris: Presses universitaires de France, 1964.
39. Beery KE. Administration, scoring and teaching manual for the Beery-Buktenica developmental test for visual-motor integration. 5th ed. Amsterdam: Pearson Assessment, 1997.
40. Nagarajan R, Sarma MK, Thomas MA, et al. Neuropsychological function and cerebral metabolites in HIV-infected youth. J Neuroimmune Pharmacol 2012; 7:981-90.
41. Jeremy RJ, Kim S, Nozyce M, et al. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics 2005; 115:380-7.
42. Simioni S, Cavassini M, Annoni JM, et al. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 2010; 24:1243-50.
43. Heaton RK, Clifford DB, Franklin DR, et al. HIV-Associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75:2087-96.
44. Meyer ACL, Boscardin WJ, Kwasa JK, Price RW. Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-Associated neurocognitive disorders?. Impact of false-positive rates on prevalence and power. Neuroepidemiology 2013; 41:208-16.
45. Schouten J, Cinque P, GisslenM, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: a review. AIDS 2011; 25:561-75.
46. Valcour V, Chalermchai T, Sailasuta N, et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis 2012; 206:275-82.
47. De OnisM, Blössner M, Borghi E. Prevalence and trends of stunting among pre-school children, 1990-2020. Public Health Nutr 2012; 15:142-8.
48. Waber DP, Bryce CP, Fitzmaurice GM, et al. Neuropsychological outcomes at midlife following moderate to severe malnutrition in infancy. Neuropsychology 2014; 28:530-40.